Influence of glucuronidation and reduction modifications of resveratrol on its biological activities (Q39147997)

9 September 2017

Influence of glucuronidation and reduction modifications of resveratrol on its biological activities (English)

1 reference

9 September 2017

Dong-Liang Lu

1

1 reference

9 September 2017

De-Jun Ding

2

1 reference

9 September 2017

Wen-Jing Yan

3

1 reference

9 September 2017

Ran-Ran Li

4

1 reference

9 September 2017

Fang Dai

5

1 reference

9 September 2017

Qi Wang

6

1 reference

9 September 2017

Sha-Sha Yu

7

1 reference

9 September 2017

Yan Li

8

1 reference

9 September 2017

Xiao-Ling Jin

9

1 reference

9 September 2017

Bo Zhou

10

1 reference

9 September 2017

23 May 2013

1 reference

9 September 2017

1 reference

9 September 2017

14

1 reference

9 September 2017

1094-1104

1 reference

9 September 2017

9

1 reference

Resveratrol ameliorates aging-related metabolic phenotypes by inhibiting cAMP phosphodiesterases

9 September 2017

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.201300080

Resveratrol and its analogs: defense against cancer, coronary disease and neurodegenerative maladies or just a fad?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.201300080

Grapes and human health: a perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.201300080

Therapeutic potential of resveratrol: the in vivo evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.201300080

Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.201300080

Cancer chemopreventive activity of resveratrol, a natural product derived from grapes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.201300080

Administration of resveratrol: What formulation solutions to bioavailability limitations?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.201300080

Resveratrol bioavailability and toxicity in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.201300080

Clinical pharmacology of resveratrol and its metabolites in colorectal cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.201300080

Quantification of free and protein-bound trans-resveratrol metabolites and identification of trans-resveratrol-C/O-conjugated diglucuronides - two novel resveratrol metabolites in human plasma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.201300080

Phase I dose escalation pharmacokinetic study in healthy volunteers of resveratrol, a potential cancer chemopreventive agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.201300080

Quantitation of trans-resveratrol and detection of its metabolites in human plasma and urine by high performance liquid chromatography

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.201300080

Bioavailability of trans-resveratrol from red wine in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.201300080

Bioactivity and metabolism of trans-resveratrol orally administered to Wistar rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.201300080

Identification of the major metabolites of resveratrol in rat urine by HPLC-MS/MS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.201300080

High absorption but very low bioavailability of oral resveratrol in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.201300080

Human hepatic cell uptake of resveratrol: involvement of both passive diffusion and carrier-mediated process

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.201300080

Resveratrol transport and metabolism by human intestinal Caco-2 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.201300080

Metabolism and disposition of resveratrol in rats: extent of absorption, glucuronidation, and enterohepatic recirculation evidenced by a linked-rat model

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.201300080

Drinking your health? It's too early to say.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.201300080

Resveratrol metabolites have an antiproliferative effect on intestinal epithelial cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.201300080

Selective synthesis and biological evaluation of sulfate-conjugated resveratrol metabolites.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.201300080

Pleiotropic mechanisms facilitated by resveratrol and its metabolites.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.201300080

Dihydro-resveratrol--a potent dietary polyphenol.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.201300080

Antitumor activity of resveratrol and its sulfated metabolites against human breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.201300080

Resveratrol glucuronides as the metabolites of resveratrol in humans: characterization, synthesis, and anti-HIV activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.201300080

Hypohalous acid-mediated halogenation of resveratrol and its role in antioxidant and antimicrobial activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.201300080

Finding more active antioxidants and cancer chemoprevention agents by elongating the conjugated links of resveratrol.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.201300080

Hybrid-increased radical-scavenging activity of resveratrol derivatives by incorporating a chroman moiety of vitamin E.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.201300080

Radical-scavenging activity and mechanism of resveratrol-oriented analogues: influence of the solvent, radical, and substitution.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.201300080

A concise synthesis of the 3-O-beta-D- and 4'-O-beta-D-glucuronide conjugates of trans-resveratrol

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.201300080

A concise synthesis of glucuronide metabolites of urolithin-B, resveratrol, and hydroxytyrosol.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.201300080

Stereoselective binding of human serum albumin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.201300080

Design, synthesis and spectroscopic studies of resveratrol aliphatic acid ligands of human serum albumin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.201300080

Resveratrol binding to human serum albumin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.201300080

NMR spectroscopy techniques for screening and identifying ligand binding to protein receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.201300080

The role of oxidative stress in carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.201300080

Radical causes of cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.201300080

The ferric reducing ability of plasma (FRAP) as a measure of "antioxidant power": the FRAP assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.201300080

A theoretical antioxidant pharmacophore for resveratrol

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.201300080

Structural basis for antioxidant activity of trans-resveratrol: ab initio calculations and crystal and molecular structure

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.201300080

Density functional theory calculations for resveratrol

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.201300080

Efficiency and mechanism of the antioxidant action of trans-resveratrol and its analogues in the radical liposome oxidation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.201300080

Cellular apoptosis and cytotoxicity of phenolic compounds: a quantitative structure-activity relationship study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.201300080

Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.201300080

21 January 2018

Inflammation and cancer

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.201300080

Potential of resveratrol in anticancer and anti-inflammatory therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.201300080

21 January 2018

Cyclooxygenases 1 and 2

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.201300080

Regulation of the expression of inducible nitric oxide synthase

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.201300080

Synthesis and biological evaluation of a library of resveratrol analogues as inhibitors of COX-1, COX-2 and NF-kappaB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.201300080

Resveratrol analogues as selective cyclooxygenase-2 inhibitors: synthesis and structure-activity relationship

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.201300080

Cancer chemopreventive and antioxidant activities of pterostilbene, a naturally occurring analogue of resveratrol

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.201300080

Paradoxical effects of resveratrol on the two prostaglandin H synthases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.201300080

Kinetic basis for selective inhibition of cyclo-oxygenases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.201300080

Characterization of immunological activities of peanut stilbenoids, arachidin-1, piceatannol, and resveratrol on lipopolysaccharide-induced inflammation of RAW 264.7 macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.201300080

Effects of resveratrol-related hydroxystilbenes on the nitric oxide production in macrophage cells: structural requirements and mechanism of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.201300080

Inhibitors from rhubarb on lipopolysaccharide-induced nitric oxide production in macrophages: structural requirements of stilbenes for the activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.201300080

A new approach for measurement of cytotoxicity using colorimetric assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.201300080

Glucuronidase deconjugation in inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.201300080

Human organic anion transporters 1 (hOAT1/SLC22A6) and 3 (hOAT3/SLC22A8) transport edaravone (MCI-186; 3-methyl-1-phenyl-2-pyrazolin-5-one) and its sulfate conjugate

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.201300080

Characterization of mouse organic anion transporter 5 as a renal steroid sulfate transporter

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.201300080

Crystal structure analysis of warfarin binding to human serum albumin: anatomy of drug site I

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.201300080

A semiempirical free energy force field with charge-based desolvation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.201300080

LIGPLOT: a program to generate schematic diagrams of protein-ligand interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.201300080

LigPlot+: multiple ligand-protein interaction diagrams for drug discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.201300080

Measurement of protein using bicinchoninic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.201300080

Screening of Indonesian medicinal plants for inhibitor activity on nitric oxide production of RAW264.7 cells and antioxidant activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.201300080

Antioxidant and anti-inflammatory phenylpropanoid derivatives from Calamus quiquesetinervius

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.201300080

Saturation-Transfer Difference (STD) NMR: A Simple and Fast Method for Ligand Screening and Characterization of Protein Binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.201300080

21 January 2018

Identifiers

DOI

10.1002/CBIC.201300080

1 reference

9 September 2017

1 reference